A. M. Guyot-Hermann

816 total citations
17 papers, 704 citations indexed

About

A. M. Guyot-Hermann is a scholar working on Pharmaceutical Science, Materials Chemistry and Molecular Biology. According to data from OpenAlex, A. M. Guyot-Hermann has authored 17 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 7 papers in Materials Chemistry and 4 papers in Molecular Biology. Recurrent topics in A. M. Guyot-Hermann's work include Drug Solubulity and Delivery Systems (11 papers), Crystallization and Solubility Studies (7 papers) and Protein purification and stability (4 papers). A. M. Guyot-Hermann is often cited by papers focused on Drug Solubulity and Delivery Systems (11 papers), Crystallization and Solubility Studies (7 papers) and Protein purification and stability (4 papers). A. M. Guyot-Hermann collaborates with scholars based in France, Italy and Belgium. A. M. Guyot-Hermann's co-authors include Piera Di Martino, E Joiris, P. Conflant, M. Drache, J.P. Huvenne, J. C. Guyot, Chantal Lefebvre, R. Bouché, Stéphane Veesler and R. Boistelle and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Powder Technology.

In The Last Decade

A. M. Guyot-Hermann

17 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. M. Guyot-Hermann France 10 409 345 184 106 88 17 704
J. C. Guyot France 12 351 0.9× 292 0.8× 144 0.8× 95 0.9× 69 0.8× 18 562
J. G. van der Watt South Africa 12 258 0.6× 240 0.7× 109 0.6× 63 0.6× 92 1.0× 28 493
Garima Chawla India 13 438 1.1× 414 1.2× 118 0.6× 116 1.1× 151 1.7× 17 748
Yuchuan Gong United States 15 442 1.1× 364 1.1× 72 0.4× 64 0.6× 159 1.8× 23 913
Steven W. Booth United Kingdom 11 396 1.0× 198 0.6× 58 0.3× 160 1.5× 156 1.8× 20 711
Fernando Alvarez‐Núñez United States 13 333 0.8× 438 1.3× 244 1.3× 58 0.5× 164 1.9× 26 812
Yoshinobu Nakai Japan 20 632 1.5× 364 1.1× 73 0.4× 171 1.6× 269 3.1× 51 998
Vishal Koradia Denmark 11 320 0.8× 345 1.0× 158 0.9× 101 1.0× 163 1.9× 15 652
Claes Ahlneck Sweden 12 782 1.9× 452 1.3× 104 0.6× 140 1.3× 284 3.2× 14 1.2k
Peter L. D. Wildfong United States 16 314 0.8× 356 1.0× 108 0.6× 96 0.9× 145 1.6× 39 682

Countries citing papers authored by A. M. Guyot-Hermann

Since Specialization
Citations

This map shows the geographic impact of A. M. Guyot-Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Guyot-Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Guyot-Hermann more than expected).

Fields of papers citing papers by A. M. Guyot-Hermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. Guyot-Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Guyot-Hermann. The network helps show where A. M. Guyot-Hermann may publish in the future.

Co-authorship network of co-authors of A. M. Guyot-Hermann

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Guyot-Hermann. A scholar is included among the top collaborators of A. M. Guyot-Hermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Guyot-Hermann. A. M. Guyot-Hermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Guyot-Hermann, A. M., et al.. (1999). Ibuprofen Agglomerates Preparation by Phase Separation. Drug Development and Industrial Pharmacy. 25(3). 297–305. 45 indexed citations
2.
Martino, Piera Di, et al.. (1999). Thermal Analysis And Powder X-Ray Diffraction Study of Terpin: Evidence of a eutectic ‘hydrate/anhydrous form’. Journal of Thermal Analysis and Calorimetry. 57(1). 95–109. 4 indexed citations
3.
Joiris, E, et al.. (1998). Compression Behavior of Orthorhombic Paracetamol. Pharmaceutical Research. 15(7). 1122–1130. 254 indexed citations
4.
Guyot-Hermann, A. M., et al.. (1998). Ground and native crystals: comparison of compression capacity and dissolution rate. International Journal of Pharmaceutics. 170(1). 51–61. 18 indexed citations
5.
Martino, Piera Di, et al.. (1997). An attempt at explaining the variability of the compression capacity of lactose. 21(5). 66–78. 1 indexed citations
6.
Martino, Piera Di, P. Conflant, M. Drache, J.P. Huvenne, & A. M. Guyot-Hermann. (1997). Preparation and physical characterization of forms II and III of paracetamol. Journal of thermal analysis. 48(3). 447–458. 152 indexed citations
7.
Barthélémy, Christine, et al.. (1997). Investigation on a New Modified USP Xanthan with Tablet-Disintegrating Properties. Drug Development and Industrial Pharmacy. 23(1). 19–26. 4 indexed citations
8.
Guyot-Hermann, A. M., J. C. Guyot, P. Conflant, et al.. (1995). Pure Paracetamol for direct compression Part I. Development of sintered-like crystals of Paracetamol. Powder Technology. 82(2). 123–128. 45 indexed citations
9.
Martino, Piera Di, et al.. (1993). The batch-to-batch non-reproducibility of the compression ability of lactose. Reasons and detection.. Unicam Scientific Publications (University of Camerino). 3(1). 436–441. 6 indexed citations
10.
Guyot-Hermann, A. M., et al.. (1992). Elaboration and Physical Study of an Oxodipine Solid Dispersion in Order to formulate Tablets. Drug Development and Industrial Pharmacy. 18(8). 811–827. 11 indexed citations
11.
Veesler, Stéphane, R. Boistelle, André Delacourte, J. C. Guyot, & A. M. Guyot-Hermann. (1992). Influence of structure and size of crystalline aggregates on their compression ability. Drug Development and Industrial Pharmacy. 18(5). 539–560. 4 indexed citations
12.
Guyot-Hermann, A. M., et al.. (1988). Calculation of Disintecrant Critical Concentration in Order to Optimize Tablets Disintegration. Drug Development and Industrial Pharmacy. 14(15-17). 2321–2339. 12 indexed citations
13.
Lefebvre, C., Christine Barthélémy, A. M. Guyot-Hermann, & J. C. Guyot. (1988). An Attempt at Bringing to Light a “Phase Inversion” in a Binary Mixture of Two Dimensional Rounded Particles. Drug Development and Industrial Pharmacy. 14(15-17). 2443–2465. 9 indexed citations
14.
Lefebvre, Chantal, et al.. (1987). Study of Different Crystalline forms of Mannitol: Comparative Behaviour under Compression. Drug Development and Industrial Pharmacy. 13(9-11). 1533–1546. 76 indexed citations
15.
Guyot-Hermann, A. M., et al.. (1981). Disintegration Mechanisms of Tablets Containing Starches. Hypothesis About the Particle-Particle Repulsive Force. Drug Development and Industrial Pharmacy. 7(2). 155–177. 41 indexed citations
16.
Colombo, Paolo, et al.. (1981). Disintegrating Force and Tablet Properties. Drug Development and Industrial Pharmacy. 7(2). 135–153. 21 indexed citations
17.
Bonnet, Claudie, Hervé Robert, & A. M. Guyot-Hermann. (1975). [Improvement in performances of an apparatus testing membrane resorption in vitro, by automatic adjustment and regulation of pH].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(2). 121–31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026